Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Julia, Stockmann"'
Autor:
Hannah Stocker, Andreas Nabers, Laura Perna, Tobias Möllers, Dan Rujescu, Annette M. Hartmann, Bernd Holleczek, Ben Schöttker, Julia Stockmann, Klaus Gerwert, Hermann Brenner
Publikováno v:
Translational Psychiatry, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Alzheimer’s disease is highly heritable and characterized by amyloid plaques and tau tangles in the brain. The aim of this study was to investigate the association between genetic predisposition, Aβ misfolding in blood plasma, a unique ma
Externí odkaz:
https://doaj.org/article/984ebc39339c484e8fbc41bf5cc52ec5
Autor:
Julia Stockmann, Inge M. W. Verberk, Nina Timmesfeld, Robin Denz, Brian Budde, Julia Lange-Leifhelm, Philip Scheltens, Wiesje M. van der Flier, Andreas Nabers, Charlotte E. Teunissen, Klaus Gerwert
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Abstract Background We evaluated Aβ misfolding in combination with Aβ42/40 ratio as a prognostic tool for future clinical progression to mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) in individuals with subjective co
Externí odkaz:
https://doaj.org/article/01b9f2a3ace648689f1dd585d885dfe9
Autor:
Julia Stockmann, Inge M. W. Verberk, Nina Timmesfeld, Robin Denz, Brian Budde, Julia Lange-Leifhelm, Philip Scheltens, Wiesje M. van der Flier, Andreas Nabers, Charlotte E. Teunissen, Klaus Gerwert
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-3 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/dc552c7abe4549e79254025b8b106f5d
Autor:
Léon, Beyer, Hannah, Stocker, Dan, Rujescu, Bernd, Holleczek, Julia, Stockmann, Andreas, Nabers, Hermann, Brenner, Klaus, Gerwert
Publikováno v:
Alzheimer's & Dementia. 19:1020-1028
Blood-based biomarkers for Alzheimer's disease (AD) are urgently needed. Here, four plasma biomarkers were measured at baseline in a community-based cohort followed over 17 years, and the association with clinical AD risk was determined.Amyloid beta
Autor:
Hannah Stocker, Léon Beyer, Laura Perna, Dan Rujescu, Bernd Holleczek, Konrad Beyreuther, Julia Stockmann, Ben Schöttker, Klaus Gerwert, Hermann Brenner
Publikováno v:
Alzheimer's & Dementia. 19:25-35
Blood biomarkers for Alzheimer's disease (AD) are the future of AD risk assessment. The aim of this study was to determine the association between plasma-measured phosphorylated tau (p-tau181), glial fibrillary acidic protein (GFAP), and neurofilamen
Autor:
Philip Scheltens, Nina Timmesfeld, Inge M.W. Verberk, Brian Budde, Julia Stockmann, Charlotte E. Teunissen, Andreas Nabers, Julia Lange-Leifhelm, Wiesje M. van der Flier, Klaus Gerwert, Robin Denz
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Stockmann, J, Verberk, I M W, Timmesfeld, N, Denz, R, Budde, B, Lange-Leifhelm, J, Scheltens, P, van der Flier, W M, Nabers, A, Teunissen, C E & Gerwert, K 2020, ' Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline ', Alzheimer's Research and Therapy, vol. 12, no. 1, 169 . https://doi.org/10.1186/s13195-020-00738-8
Alzheimer's Research & Therapy
Alzheimer's Research and Therapy, 12(1):169. BioMed Central
Stockmann, J, Verberk, I M W, Timmesfeld, N, Denz, R, Budde, B, Lange-Leifhelm, J, Scheltens, P, van der Flier, W M, Nabers, A, Teunissen, C E & Gerwert, K 2020, ' Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline ', Alzheimer's Research and Therapy, vol. 12, no. 1, 169 . https://doi.org/10.1186/s13195-020-00738-8
Alzheimer's Research & Therapy
Alzheimer's Research and Therapy, 12(1):169. BioMed Central
Background We evaluated Aβ misfolding in combination with Aβ42/40 ratio as a prognostic tool for future clinical progression to mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (AD) in individuals with subjective cognitive d
Autor:
Julia Stockmann, Klaus Gerwert
Publikováno v:
BIOspektrum. 26:259-261
Alzheimer’s disease cannot be cured today. In addition to a drug, a predictive blood biomarker is urgently needed to identify high-risk subjects in early cognitively less impaired stages. Here, a biomarker is presented that uses the secondary struc
Autor:
Christoph Helmut Rudi Senges, Robert Kourist, Raquel S. Correia Cordeiro, Dennis Sander, Julia Stockmann, Derek T. Logan, Maria Håkansson, Julia E. Bandow, Octavia Natascha Kracht
Publikováno v:
Journal of Biotechnology. 297:71-77
With more than 50,000 members, terpenoids are one of the most important classes of natural products and show an enormous diversity. Due to their unique odors and specific bioactivities they already find wide application in the flavor, fragrance and p
Autor:
Nathalie Woitzik, Sandy Galkowski, Klaus Gerwert, Léon Beyer, Jörn Güldenhaupt, Julia Stockmann
Publikováno v:
Alzheimer's & Dementia. 16
Autor:
Andreas Nabers, Hannah Stocker, Julia Stockmann, Ben Schöttker, Tobias Möllers, Bernd Holleczek, Annette M. Hartmann, Dan Rujescu, Hermann Brenner, Laura Perna, Klaus Gerwert
Publikováno v:
Translational Psychiatry
Translational Psychiatry, Vol 11, Iss 1, Pp 1-11 (2021)
Translational Psychiatry, Vol 11, Iss 1, Pp 1-11 (2021)
Alzheimer’s disease is highly heritable and characterized by amyloid plaques and tau tangles in the brain. The aim of this study was to investigate the association between genetic predisposition, Aβ misfolding in blood plasma, a unique marker of A